TITLE

Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses

AUTHOR(S)
Taylor, David; Taylor, D
PUB. DATE
November 1995
SOURCE
British Journal of Psychiatry;Nov95, Vol. 167, p575
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: The selective serotonin reuptake inhibitors (SSRIs) are now widely used in the treatment of depressive illness. Interest has grown in the use of SSRIs as alternatives to tricyclic antidepressants (TCAs) and in the therapeutic use of combinations of SSRIs and TCAs in refractory depression.Method: MEDLINE and PSYCLit literature searches were conducted. Reference sections from papers retrieved were scrutinised for other relevant reports.Results: Of 41 relevant articles identified, 35 were selected for review.Conclusions: Fluoxetine, fluvoxamine, paroxetine and sertraline may substantially increase TCA plasma levels when given concurrently. Such interactions may give rise to adverse effects. The effect of sertraline may be less profound than that of fluoxetine, fluvoxamine and paroxetine. Limited data suggest that citalopram may not affect TCA serum levels. There is scant literature evidence to support the use of SSRIs in combination with TCAs as a treatment for refractory depression.
ACCESSION #
25173958

 

Related Articles

  • Combination treatment of depression. Cowen, P. J.; Power, A. C. // British Journal of Psychiatry;Feb93, Vol. 162, p266 

    A letter to the editor is presented in response to an article about the benefit of combined treatment with selective 5-HT uptake blockers and tricyclic antidepressants in depressed patients in the October 1992 issue.

  • Compulsive personality as predictor of response to serotonergic antidepressants. Pollitt, John; Tyrer, Peter; Pollitt, J; Tyrer, P // British Journal of Psychiatry;Dec92, Vol. 161, p836 

    The article comments on "Compulsive personality as predictor of response to serotonergic antidepressants," a 1991 study by M. Ansseau, B. Troisfontaines, P. Papart and colleagues, published in the volume 303 of this journal. The study postulated that there may be a link between depression and...

  • Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Westanmo, Anders D.; Gayken, Jon; Haight, Robert // American Journal of Health-System Pharmacy;12/1/2005, Vol. 62 Issue 23, p2481 

    Purpose. The pharmacology, pharmacokinetics, efficacy, safety, drug interactions, dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic peripheral neuropathy, and stress urinary incontinence are reviewed. Summary. Duloxetine is a balanced...

  • Relighting the Inner Flame. Klotter, Jule // Townsend Letter;Jan2007, Issue 282, p72 

    The article discusses the significance of selective serotonin reuptake inhibitors (SSRI) in treating mental depression in the U.S. The author discusses the withdrawal effects of the drug and argues that the drugs are necessary for the patient's health. Moreover, she emphasizes the importance of...

  • SSRI combination treatment for depression. Hunchak, J. // Canadian Journal of Psychiatry;Jun1997, Vol. 42 Issue 5, p531 

    A letter to the editor about the use of selective serotonin reuptake inhibitors combination to treat depression is presented.

  • Re: A time to bury tricyclic antidepressants or to praise them? Berber, Mark J.; Berber, M J // Canadian Journal of Psychiatry;Aug1997 Supplement, Vol. 42 Issue 6, p663 

    A letter to the editor is presented in response to the article "A Time to Bury Tricyclic Antidepressants or to Praise Them?" in the previous issue.

  • Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. Austin, M.-P.V.; Souza, F.G.M.; Goodwin, G.M.; Austin, M P; Souza, F G // British Journal of Psychiatry;Oct91, Vol. 159, p510 

    A quantitative analysis was used to examine the efficacy of lithium augmentation in the acute treatment of depressed patients resistant to a standard trial of an antidepressant. Effect sizes were measured by the odds ratio using the Mantel-Haenszel method. Only controlled trials were included in...

  • Wife sneaks SSRI into her depressed husband's tea.  // Pulse;1/12/2004, Vol. 64 Issue 2, p33 

    Offers advice to the wife of a mentally depressed man who refuses to take the selective serotonin reuptake inhibitors (SSRI) prescribed by the doctors. Reasons behind the man's refusal to take the drugs; Side-effects of SSRI; Patient's rights issues involved in the situation.

  • Wife sneaks SSRI into her depressed husband's tea.  // Pulse;1/12/2004, Vol. 64 Issue 2, p30 

    Offers advice to the wife of a mentally depressed man who refuses to take the selective serotonin reuptake inhibitors (SSRI) prescribed by the doctors. Reasons behind the man's refusal to take the drugs; Side-effects of SSRI; Ethical issues associated with the situation.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics